Table 2.
Ligands | Pharmacological Profile | Refs. |
---|---|---|
(2R,4R)-APDC | Broad spectrum group II mGlu agonist, also active at other mGlu receptors | [1, 103] |
DGC-IV | Broad spectrum group II mGlu agonist | [1, 104] |
NAAG | mGlu3 agonist | [123, 124] |
LY354740 | mGlu2/3 agonist | [13, 106, 107] |
LY379268 | mGlu2/3 agonist | [13, 106, 107] |
LY341495 | Broad spectrum group II mGlu antagonist | [110] |
LY541850 | Mixed ligand (mGlu2 agonist / mGlu3 antagonist) | [1] |
LY566332 | mGlu2 PAM | [99, 113] |
LY2389575 | mGlu3 NAM | [114] |
BINA | mGlu2 PAM | [112] |
ML 337 | mGlu3 NAM | [116] |
DN10 | Nanobody, mGlu2 PAM, partial agonist at mGlu2 | [17] |
DN13 | Nanobody, mGlu2 PAM | [17] |